To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Large-scale trial comparing topical and intravenous TXA efficacy in total knee arthroplasty

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2019

Large-scale trial comparing topical and intravenous TXA efficacy in total knee arthroplasty

Vol: 8| Issue: 2| Number:77| ISSN#: 2564-2537
Study Type:N/A
OE Level Evidence:2
Journal Level of Evidence:1

Intravenous Versus Topical Tranexamic Acid in Total Knee Arthroplasty: Both Effective in a Randomized Clinical Trial of 640 Patients

J Bone Joint Surg Am. 2018 Jun 20;100(12):1023-1029

Contributing Authors:
RT Trousdale EP Su F Boettner MP Figgie DJ Mayman SB Haas MJ Taunton MP Abdel YY Lee RJ Sierra M Pagano BP Chalmers

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

664 patients scheduled for total knee arthroplasty were randomized to either topical tranexamic acid or intravenous tranexamic acid. Patients were assessed for total blood loss, postoperative blood loss, and the incidence of transfusion. Results demonstrated that despite the statistically significantly lower total and postoperative blood loss in the intravenous group, there was no significant diff...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue